Therasse, P.A.J.P.

response tumor criteria lesion recist patient study disease trial progression cancer treatment measurement recnac evaluation diameter esnopser response rate agent increase phase target lesions tumor response assessment chapter change product objective target metastase table group imaging response criteria cancer institute number unidimensional anticancer agents result image review measure response evaluation criteria bidimensional as-mri method airetirc tissue tumor lesions disease progression recist criteria guideline metastatic anticancer survival criterion decrease locno objective tumor response resonance imaging response evaluation activity bone metastases phase ii baseline institute examination comparison validation studies therapy technique marrow endpoint phase iii trials respon paper benefit protocol development prostate